Identification of a brain circuit implicated in Alzheimer disease and schizophrenia could aid in comprehension of brain disorders and point to prevention strategies.
Pain relief is better with a triple combination medication that includes acetaminophen than with acetaminophen by itself, researchers found, suggesting a new therapeutic option.
Study results suggest that more stimulating work environments may help people retain their cognitive abilities.
The use of a stroke emergency mobile unit speeds thrombolysis and thus improves short-term outcomes, with no risk to patients’ safety.
The ketogenic and the modified Atkins diets, high in fat and low in carbohydrates, could reduce these seizures, suggesting that clinicians bring them into the treatment discussion.
The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.
These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.
Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.
Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.
As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.
Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.
Determining who is at risk for MS remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. MRI may help.
The emergence of Ioflupane I 123 Injection (DaTSCAN) provides clinicians with helpful information to differentiate idiopathic Parkinson disease from other diseases.
Could the common herpes simplex virus be associated with Alzheimer disease? These researchers think it is possible.
Patients with juvenile myoclonic epilepsy appear to have modest cognitive defects and imaging abnormalities early on that are unlikely to be associated with anti-epileptic therapy. This is a clear departure from traditional teaching.